Chlorantraniliprole 200 g/L SC is an aqueous suspension concentrate in which finely milled active-ingredient particles are dispersed through a structured liquid system. For buyers, the commercial question is not only whether the label concentration is declared correctly. The more useful question is whether the formulation remains homogeneous, pourable, redispersible and biologically consistent through transport, storage and application. A release decision therefore needs a stability package that connects the Certificate of Analysis (CoA), formulation data, container compatibility and the registration specification for the intended market.
This guide sets out a buyer-oriented test framework. It distinguishes routine lot acceptance from development studies and from data that a national registration authority may request. Test conditions and acceptance limits should be agreed with the formulator, the contract laboratory and the competent authority before a purchase order is released.
An SC normally combines chlorantraniliprole technical material with water, a dispersant system, wetting agent, rheology modifier, antifoam and preservatives or other auxiliaries selected for the target formulation. The exact composition is formulation-specific and is not inferred from the nominal 200 g/L declaration. The active ingredient must remain adequately wetted and deflocculated, while the continuous phase must provide enough structure to limit sedimentation without making the product difficult to pour or dilute.
Chlorantraniliprole has limited water solubility, which is one reason SC and water-dispersible granule formats are widely studied for this active ingredient. Peer-reviewed formulation research reports that surfactant selection, milling history and particle-size distribution can materially affect dispersibility and physical stability. Those findings support a practical procurement principle: a concentration result alone cannot demonstrate SC quality.
· Particle system: milling and wetting control the distribution of suspended particles, agglomeration tendency and spray-tank dispersion.
· Interfacial system: dispersants and wetting agents influence flocculation, sediment shape and redispersibility.
· Rheology system: viscosity and yield behavior balance storage stability against pourability and dosing accuracy.
· Continuous phase: pH, water quality, preservatives and freeze sensitivity can change during storage.
The buyer should request a product specification that identifies the formulation type, active-ingredient assay basis, appearance, density or relative density where used, pH range, suspensibility method, wet-sieve requirement, particle-size method and storage statement. A supplier specification is a commercial control document; it does not automatically replace a country-specific registration specification.
A useful package combines baseline characterization with stress studies and a retained-sample program. Each sample should be traceable to a batch number, manufacturing date, package, laboratory method and test date. The same analytical methods should be used when possible so that changes are attributable to storage rather than method variation.
Test | Decision supported | What to compare |
Active-ingredient assay and relevant impurities | Identity and chemical content remain within the agreed specification | Initial result versus post-stress result and CoA |
Appearance, sediment and redispersibility | Detects hard cake, phase separation or irreversible settling | Visual record, mixing effort and uniformity after redispersion |
Suspensibility | Shows whether the active remains uniformly available after dilution | Method-defined suspended fraction and repeatability |
Wet sieve | Detects oversize particles, agglomerates or foreign matter | Residue against the agreed method and limit |
Particle-size distribution | Monitors milling, aggregation and spray behavior risk | D10/D50/D90 or another validated reporting basis |
pH and viscosity | Tracks chemical and physical drift that can affect handling | Initial and aged values at controlled temperature |
Suspensibility and redispersibility should not be treated as interchangeable. A formulation may redisperse after storage but still produce poor uniformity in a standardized dilution test. Conversely, a sample can appear acceptable in a jar while its particle-size tail or wet-sieve residue signals a developing aggregation problem.
Accelerated storage is a screening tool for formulation robustness and packaging risk. A buyer should request a protocol that defines temperature, duration, container orientation, sampling points and the tests performed before and after storage. The protocol should state whether the sample is opened during the study because repeated opening changes moisture, contamination and headspace conditions.
Long-term storage at the proposed label condition is the more direct evidence for shelf-life support. Accelerated results can identify weak formulations earlier, but they should not be used to claim a shelf life without a scientifically justified correlation and the data required by the relevant authority. The final shelf-life statement is controlled by the registered product and jurisdiction, not by a general industry rule.
1. Record baseline assay, impurities, appearance, pH, viscosity, particle size, wet sieve and suspensibility.
2. Store unopened units in the proposed commercial container at the agreed accelerated condition.
3. Inspect at predefined intervals and document sediment height, caking, color, leakage and package deformation.
4. Mix using a defined, reproducible procedure before sampling; record whether manual agitation is sufficient.
5. Repeat the baseline tests and compare trends, not only pass/fail endpoints.
Trend review matters because gradual viscosity increase, a widening particle-size distribution or increasing sieve residue may precede a visible failure. The supplier and buyer should define an escalation rule for out-of-trend results even when the batch remains inside a broad commercial range.
Water-based SC products can be vulnerable to freezing, thawing and repeated temperature changes. A freeze-thaw study should use the actual package and document the number of cycles, exposure time and thawing procedure. The post-cycle review should include caking, phase separation, redispersibility, suspensibility, particle size, viscosity and assay. A result that becomes uniform only after unusually intense mixing may be unsuitable for normal farm or distributor handling.
Heat-cold cycling can expose mismatches between the dispersant system, rheology modifier and package. Temperature transitions may accelerate particle growth, alter viscosity or stress seals. Where international distribution is planned, the buyer should add a transport assessment that considers vibration, orientation, headspace and likely warehouse conditions. Transport simulation is not a substitute for chemical stability testing; it is a complement to it.
The diluted product should be evaluated under the method specified in the agreed quality standard. The laboratory should record water quality, dilution order, agitation, standing time and sampling position. These details influence results and must be controlled for meaningful lot-to-lot comparison. The buyer should also request a practical tank-mix observation where permitted by the product development plan, while recognizing that tank compatibility depends on the label and local use pattern.
Wet-sieve residue is a simple screen for large agglomerates and foreign material. Particle-size analysis adds resolution by showing whether the bulk distribution has shifted. A method report should identify instrument type, dispersion medium, sample preparation and the reporting parameters. Because a published research result for a laboratory nanosuspension is not a universal commercial specification, it should be used as formulation insight rather than copied as a release limit.
Viscosity should be measured with a defined instrument, spindle or geometry, shear condition and temperature. A single number without those conditions is difficult to compare. pH should be measured using a calibrated method and recorded with temperature. Redispersibility should describe the agitation energy and time required to restore a uniform suspension. The test is especially important after storage because the sediment structure, rather than initial appearance, often determines handling performance.
The commercial package is part of the formulation system. Buyers should request compatibility data for the proposed bottle, jerrycan, cap, liner, seal and label. The review should cover leakage, swelling, embrittlement, stress cracking, cap torque, seal integrity, label adhesion and visible interaction between formulation and package. Headspace and fill volume should match the intended packaging process.
Samples should be stored in the actual package rather than only in laboratory glassware. Packaging observations should be paired with assay, pH, viscosity and appearance results because a package interaction can be chemical, physical or both. When the product is exported, packaging validation should consider the temperature range and transport duration stated in the supply plan. A package that performs in a controlled room may not perform equivalently during a long distribution cycle.
A CoA should be reviewed as evidence for a specific batch, not as a generic marketing sheet. At minimum, the buyer should verify product name, formulation type, batch number, manufacture date, active-ingredient assay, relevant physical tests, specification limits, test methods, laboratory authorization and approval signature. Any method that is proprietary or modified should be described sufficiently for technical review.
Before purchase, the buyer should request a representative sealed sample and a matching CoA. The sample should be tested by an independent or qualified laboratory for the agreed critical quality attributes. The acceptance plan should define sample quantity, retain samples, chain of custody, dispute testing and the action taken when results are out of specification or out of trend.
· Confirm that the sample label, seal and batch number match the CoA.
· Compare assay and impurity results with the registered or agreed specification.
· Check physical performance before and after the agreed stress condition.
· Review SDS, label, packaging drawings and transport classification where applicable.
· Record deviations and require a written corrective-action response before release.
chlorantraniliprole technical material information from Red Sun can be used as a starting point for commercial specification dialogue. Buyers comparing a broader chlorantraniliprole product category should still confirm the exact formulation, pack and documentation. Final acceptance remains dependent on the agreed supply specification and destination-market requirements; a chlorantraniliprole supplier quotation does not replace registration review.
Stability testing supports product quality and registration dossiers, but the required data package differs by jurisdiction, formulation type and intended use. National authorities may prescribe specific analytical methods, accelerated conditions, shelf-life evidence, packaging studies, efficacy data, residue data and label statements. The buyer should map the test plan to the destination registration before treating a supplier report as dossier-ready.
Chlorantraniliprole is an IRAC Group 28 ryanodine receptor activator. IRAC guidance treats Group 28 insecticides as one resistance-management group for rotation and program design. A stable SC does not remove resistance risk. The registered label, local integrated pest management program and IRAC recommendations should govern application timing, rate, spray interval and rotation with effective modes of action. Claims about efficacy, crop safety or resistance control require local supporting data and should not be inferred from physical stability alone.
Buying situation | Minimum evidence to request | Escalation trigger |
First supplier qualification | Representative sample, CoA, baseline physical profile, accelerated screen and package details | Missing methods, unmatched batch data or irreversible sediment |
Routine lot release | Assay, appearance, pH, viscosity, suspensibility and wet sieve against the signed specification | Out-of-specification or unexplained trend versus retained sample |
New export market | Destination registration review, label and SDS, long-term data plan, packaging and transport assessment | Local authority requires data not covered by supplier protocol |
Formulation change | Comparability study covering particle size, redispersibility, stability and application-relevant properties | Changed raw material, milling process, package or impurity profile |
No. Assay confirms chemical content but does not demonstrate suspensibility, redispersibility, particle-size control, package compatibility or storage robustness. A release decision should use the complete agreed critical-quality-attribute set.
Accelerated storage is useful for screening and development. It should not automatically replace long-term evidence or the data format required by the destination registration authority.
No. Particle-size limits depend on formulation design, method, application profile and registration specification. Published studies can inform development, but commercial limits should be technically justified and method-specific.
Container materials, seals and headspace can affect leakage, deformation, contamination and formulation quality. Actual commercial packaging provides more relevant evidence than a laboratory container alone.
No. Stability supports consistent product quality. Resistance management remains dependent on the registered label, IRAC guidance, rotation of effective modes of action and local integrated pest management practice.
A buyer evaluating chlorantraniliprole 200 g/L SC should request a linked evidence package: baseline CoA data, accelerated and long-term stability, freeze-thaw and temperature-cycle results, physical performance tests, packaging compatibility and a clear lot-acceptance plan. The most useful package explains methods, sample identity, trends and decision limits rather than presenting isolated numbers. For a destination-market quotation or specification review, Red Sun’s chlorantraniliprole product team can provide the product information needed to define the next technical discussion, subject to applicable registration and label requirements.
